| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aldosterone blockade in heart failure
|
Struthers, Allan D
|
|
2004
|
|
1_suppl |
p. 23-27
|
artikel
|
| 2 |
Analysis of responses to angiotensin II in the mouse
|
Bivalacqua, Trinity J
|
|
2001
|
|
1_suppl |
p. S48-S53
|
artikel
|
| 3 |
Angiotensin II blockade causes acute renal failure in eNOS-deficient mice
|
Schnermann, Jürgen
|
|
2001
|
|
1_suppl |
p. S199-S203
|
artikel
|
| 4 |
Angiotensin inhibition in heart failure
|
Mcmurray, John JV
|
|
2004
|
|
1_suppl |
p. 17-22
|
artikel
|
| 5 |
Angiotensin Receptor Blockers: Cardiovascular Protection in the Metabolic Syndrome
|
Deedwania, Prakash C
|
|
2006
|
|
1_suppl |
p. 12-18
|
artikel
|
| 6 |
Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge
|
Allen, Andrew M
|
|
2001
|
|
1_suppl |
p. S120-S124
|
artikel
|
| 7 |
Blood Pressure Control: Stroke and Stroke Prevention
|
Diener, Hans-Christoph
|
|
2005
|
|
1_suppl |
p. S8-S11
|
artikel
|
| 8 |
Candesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophy
|
Lebeche, Djamel
|
|
2001
|
|
1_suppl |
p. S154-S161
|
artikel
|
| 9 |
Candesartan decreases the sympatho-adrenal and hormonal response to isolation stress
|
Armando, Ines
|
|
2001
|
|
1_suppl |
p. S130-S135
|
artikel
|
| 10 |
Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects
|
Casellas, Daniel
|
|
2001
|
|
1_suppl |
p. S84-S90
|
artikel
|
| 11 |
Cardiac and renal damage in the elderly hypertensive
|
Ribstein, Jean
|
|
2002
|
|
1_suppl |
p. 16-24
|
artikel
|
| 12 |
Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor
|
Jugdutt, Bodh I
|
|
2001
|
|
1_suppl |
p. S162-S166
|
artikel
|
| 13 |
Characterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries
|
Ytterberg, Hoa
|
|
2001
|
|
1_suppl |
p. S37-S41
|
artikel
|
| 14 |
Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers
|
Nickenig, Georg
|
|
2006
|
|
1_suppl |
p. 1-7
|
artikel
|
| 15 |
Cognitive decline and dementia in the elderly hypertensive
|
Hanon, Olivier
|
|
2002
|
|
1_suppl |
p. 32-38
|
artikel
|
| 16 |
Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction
|
van Rodijnen, William F
|
|
2001
|
|
1_suppl |
p. S204-S210
|
artikel
|
| 17 |
Conclusions on the management of heart failure
|
Swedberg, Karl
|
|
2004
|
|
1_suppl |
p. 34-36
|
artikel
|
| 18 |
Current guidelines in the pharmacological management of chronic heart failure
|
Metra, Marco
|
|
2004
|
|
1_suppl |
p. 11-16
|
artikel
|
| 19 |
Development of salt-sensitive hypertension in a sensory denervated model: the underlying mechanisms
|
Wang, Donna H
|
|
2001
|
|
1_suppl |
p. S125-S129
|
artikel
|
| 20 |
Diagnosis of CHF – Often a Trap in Itself
|
Lüscher, Thomas F
|
|
2000
|
|
1_suppl |
p. 7-11
|
artikel
|
| 21 |
Distinctions between non-peptide angiotensin II AT1-receptor antagonists
|
Vauquelin, Georges
|
|
2001
|
|
1_suppl |
p. S24-S31
|
artikel
|
| 22 |
Does protein binding modulate the effect of angiotensin II receptor antagonists?
|
Maillard, Marc P
|
|
2001
|
|
1_suppl |
p. S54-S58
|
artikel
|
| 23 |
Effects of low-dose candesartan on the rate of re-endothelialisation following vascular wound healing
|
Koshy, Prakash
|
|
2001
|
|
1_suppl |
p. S81-S83
|
artikel
|
| 24 |
Evidence for a cyclic AMP-dependent pathway in angiotensin AT1-receptor activation of human omental arteries
|
Ytterberg, Hoa
|
|
2001
|
|
1_suppl |
p. S42-S47
|
artikel
|
| 25 |
Facilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells
|
Mehta, Jawahar L
|
|
2001
|
|
1_suppl |
p. S70-S76
|
artikel
|
| 26 |
Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade?
|
Wagenaar, Lodewijk J
|
|
2001
|
|
1_suppl |
p. S64-S69
|
artikel
|
| 27 |
Improvements of renal lesions and function by angiotensin and endothelin receptor antagonism in nitric oxide-deficient rats
|
Boffa, Jean-Jacques
|
|
2001
|
|
1_suppl |
p. S211-S216
|
artikel
|
| 28 |
Introduction
|
Sever, Peter
|
|
2002
|
|
1_suppl |
p. S3
|
artikel
|
| 29 |
Introduction
|
McMurray, John JV
|
|
2004
|
|
1_suppl |
p. S1
|
artikel
|
| 30 |
Neurohumoral Blockade in CHF Management
|
Willenbrock, Roland
|
|
2000
|
|
1_suppl |
p. 24-30
|
artikel
|
| 31 |
Organisation and functional role of the brain angiotensin system
|
Llorens-Cortes, Catherine
|
|
2002
|
|
1_suppl |
p. 39-48
|
artikel
|
| 32 |
Persistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats
|
Skov, Karin
|
|
2001
|
|
1_suppl |
p. S91-S94
|
artikel
|
| 33 |
Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil
|
Papademetriou, Vasilios
|
|
2001
|
|
1_suppl |
p. S77-S80
|
artikel
|
| 34 |
Principal Results of a Prospective Randomised Controlled Study: Morbidity and Mortality after Stroke — Eprosartan Compared with Nitrendipine for Secondary Prevention (MOSES)
|
Lüders, Stephan
|
|
2005
|
|
1_suppl |
p. S12-S15
|
artikel
|
| 35 |
Reassessing guidelines for heart failure
|
Drexler, Helmut
|
|
2004
|
|
1_suppl |
p. 28-33
|
artikel
|
| 36 |
Regression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction
|
Abro, Emad
|
|
2001
|
|
1_suppl |
p. S148-S153
|
artikel
|
| 37 |
Relative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model
|
Griffin, Karen A
|
|
2001
|
|
1_suppl |
p. S191-S195
|
artikel
|
| 38 |
Reversal of cardiovascular remodelling with candesartan
|
Brown, Lindsay
|
|
2001
|
|
1_suppl |
p. S141-S147
|
artikel
|
| 39 |
Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion
|
Schulz, Rainer
|
|
2001
|
|
1_suppl |
p. S136-S140
|
artikel
|
| 40 |
Review: AT1-receptors in the central nervous system
|
Allen, Andrew M
|
|
2001
|
|
1_suppl |
p. S95-S101
|
artikel
|
| 41 |
Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
|
Morgan, Trefor
|
|
2001
|
|
1_suppl |
p. S223-S226
|
artikel
|
| 42 |
Review: Gene targeting studies of angiotensin II type 1 (AT1) receptors
|
Coffman, Thomas M
|
|
2001
|
|
1_suppl |
p. S10-S15
|
artikel
|
| 43 |
Review: Interaction among angiotensin II, nitric oxide and oxidative stress
|
Zhou, Ming-Sheng
|
|
2001
|
|
1_suppl |
p. S59-S63
|
artikel
|
| 44 |
Review: Intrarenal angiotensin II levels in normal and hypertensive states
|
Navar, L Gabriel
|
|
2001
|
|
1_suppl |
p. S176-S184
|
artikel
|
| 45 |
Review: Lessons on renal function from transgenic mice lacking different angiotensin II receptors
|
Arendshorst, William J
|
|
2001
|
|
1_suppl |
p. S167-S175
|
artikel
|
| 46 |
Review: Promise of prevention and reversal of target organ involvement in hypertension
|
Frohlich, Edward D
|
|
2001
|
|
1_suppl |
p. S4-S9
|
artikel
|
| 47 |
Review: Role of angiotensin in central regulation of sympathetic activity: effect of dietary sodium chloride
|
DiBona, Gerald F
|
|
2001
|
|
1_suppl |
p. S110-S113
|
artikel
|
| 48 |
Review: Structural requirements for signalling and regulation of AT1-receptors
|
Hunyady, László
|
|
2001
|
|
1_suppl |
p. S16-S23
|
artikel
|
| 49 |
Review: The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy
|
Hollenberg, Norman K
|
|
2001
|
|
1_suppl |
p. S185-S187
|
artikel
|
| 50 |
Review: The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia
|
Saavedra, Juan M
|
|
2001
|
|
1_suppl |
p. S102-S109
|
artikel
|
| 51 |
Role of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan
|
Vauquelin, Georges
|
|
2001
|
|
1_suppl |
p. S32-S36
|
artikel
|
| 52 |
Special management needs of the elderly hypertensive patient
|
Elliott, Henry L
|
|
2002
|
|
1_suppl |
p. 25-31
|
artikel
|
| 53 |
Specific aspects of high blood pressure in the elderly
|
Blacher, Jacques
|
|
2002
|
|
1_suppl |
p. 8-13
|
artikel
|
| 54 |
Stroke Prevention: Not all Antihypertensive Drugs are Created Equal
|
Messerli, Franz H
|
|
2005
|
|
1_suppl |
p. S4-S7
|
artikel
|
| 55 |
Targeting Hypertension with Valsartan: Lessons Learned from the Valsartan/HCTZ Versus Amlodipine in Stage II Hypertensive Patients (VAST) Trial
|
Ruilope, Luis M
|
|
2006
|
|
1_suppl |
p. 8-11
|
artikel
|
| 56 |
The effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion
|
Weinberg, Marc S
|
|
2001
|
|
1_suppl |
p. S196-S198
|
artikel
|
| 57 |
The Effects of Eprosartan on Cytoplasmic Free Calcium Mobilisation, Platelet Activation and Microparticle Formation in Hypertension. Could they be Relevant to Stroke Prevention?
|
Martínez Silvestre, Marcial
|
|
2005
|
|
1_suppl |
p. S1-S3
|
artikel
|
| 58 |
The elderly hypertensive population: what lies ahead of us?
|
Bobrie, Guillaume
|
|
2002
|
|
1_suppl |
p. 4-9
|
artikel
|
| 59 |
The epidemiology of heart failure
|
Tendera, Michal
|
|
2004
|
|
1_suppl |
p. 2-6
|
artikel
|
| 60 |
The Growing Healthcare Burden of CHF
|
Szucs, Thomas D
|
|
2000
|
|
1_suppl |
p. 2-6
|
artikel
|
| 61 |
The Importance of Early Intervention in CHF – Signs and sYmptom Relief
|
Schunkert, Heribert
|
|
2000
|
|
1_suppl |
p. 17-23
|
artikel
|
| 62 |
Therapy in the elderly hypertensive
|
Meredith, Peter A
|
|
2002
|
|
1_suppl |
p. 49-56
|
artikel
|
| 63 |
The renin-angiotensin system in obesity hypertension
|
Sharma, Arya M
|
|
2001
|
|
1_suppl |
p. S114-S119
|
artikel
|
| 64 |
The role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy
|
Weir, Matthew R
|
|
2001
|
|
1_suppl |
p. S188-S190
|
artikel
|
| 65 |
The role of the renin-angiotensin-aldosterone system in heart failure
|
Unger, Thomas
|
|
2004
|
|
1_suppl |
p. 7-10
|
artikel
|
| 66 |
The Safety and Tolerability of Candesartan Cilexetil in CHF
|
Erdmann, Erland
|
|
2000
|
|
1_suppl |
p. 31-36
|
artikel
|
| 67 |
Use of angiotensin II receptor blockers alone and in combination with other drugs: a large clinical experience trial
|
Weir, Matthew R
|
|
2001
|
|
1_suppl |
p. S217-S222
|
artikel
|
| 68 |
Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients
|
Liu, Peter P
|
|
2006
|
|
1_suppl |
p. 19-22
|
artikel
|
| 69 |
Why we Need New Strategies in CHF Management
|
Mcmurray, John
|
|
2000
|
|
1_suppl |
p. 12-16
|
artikel
|
Tijdschrift beschrijving